- Home
- BWFG vs ENTA Comparison
BWFG vs ENTA Comparison
Compare BWFG & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BWFG | ENTA |
|---|---|---|
| Founded | 2002 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 369.1M | 374.6M |
| IPO Year | 2014 | 2012 |
Fundamental Metrics
Financial Performance| Metric | BWFG | ENTA |
|---|---|---|
| Price | $47.85 | $12.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $55.00 | $20.40 |
| AVG Volume (30 Days) | 20.6K | ★ 141.5K |
| Earning Date | 04-22-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.67% | N/A |
| EPS Growth | ★ 261.79 | 29.93 |
| EPS | ★ 4.45 | N/A |
| Revenue | $2,826,000.00 | ★ $102,814,000.00 |
| Revenue This Year | $17.64 | $7.76 |
| Revenue Next Year | $6.21 | N/A |
| P/E Ratio | $10.78 | ★ N/A |
| Revenue Growth | ★ 43.96 | 16.48 |
| 52 Week Low | $26.39 | $4.09 |
| 52 Week High | $51.54 | $17.15 |
Technical Indicators
Market Signals| Indicator | BWFG | ENTA |
|---|---|---|
| Relative Strength Index (RSI) | 49.36 | 39.83 |
| Support Level | $45.46 | $12.09 |
| Resistance Level | $47.67 | $15.52 |
| Average True Range (ATR) | 1.56 | 0.76 |
| MACD | 0.16 | -0.13 |
| Stochastic Oscillator | 52.00 | 8.70 |
Price Performance
Historical ComparisonAbout BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.